Identifying cancer cachexia in patients without weight loss information: machine learning approaches to address a real-world challenge
The American Journal of Clinical Nutrition · 2022-11 · 116 (5) · 1229-1239
DOI: 10.1093/ajcn/nqac251 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The American Journal of Clinical Nutrition, 2022-11. Verfasst von Liangyu Yin und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China; Institute of Hepato…. Hauptthemen laut MEDLINE: Cachexia, Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Key Research and Development Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Diagnosing cancer cachexia relies extensively on patient-reported historic weight, and failure to accurately recall this information can lead to severe underestimation of cancer cachexia. OBJECTIVES: The present study aimed to develop inexpensive tools to facilitate the identification of cancer cachexia in patients without weight loss information. METHODS: This multicenter cohort study included 12,774 patients with cancer. Cachexia was retrospectively diagnosed using Fearon et al.'s framework. Baseline clinical features, excluding weight loss, were modeled to mimic a situation where the patient is unable to recall their weight history. Multiple machine learning (ML) models were trained using 75% of the study cohort to predict cancer cachexia, with the remaining 25% of the cohort used to assess model performance. RESULTS: The study enrolled 6730 males and 6044 females (median age = 57.5 y). Cachexia was diagnosed in 5261 (41.2%) patients and most diagnoses were made based on the weight loss criterion. A 15-variable logistic regression (LR) model mainly comprising cancer types, gastrointestinal symptoms, tumor stage, and serum biochemistry indexes was selected among the various ML models. The LR model showed good performance for predicting cachexia in the validation data (AUC = 0.763; 95% CI: 0.747, 0.780). The calibration curve of the model demonstrated good agreement between predictions and actual observations (accuracy = 0.714, κ = 0.396, sensitivity = 0.580, specificity = 0.808, positive predictive value = 0.679, negative predictive value = 0.733). Subgroup analyses showed that the model was feasible in patients with different cancer types. The model was deployed as an online calculator and a nomogram, and was exported as predictive model markup language to permit flexible, individualized risk calculation. CONCLUSIONS: We developed an ML model that can facilitate the identification of cancer cachexia in patients without weight loss information, which might improve decision-making and lead to the development of novel management strategies in cancer care. This trial was registered at https://www.chictr.org.cn as ChiCTR1800020329.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Nutrition, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China; Institute of Hepatopancreatobiliary Surgery, Southwest Hospital, Army Medical University…
- Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, China.
- Department of Clinical Nutrition, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
- Department of Medical Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China.
- Department of Comprehensive Oncology, National Cancer Center or Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Clinical Nutrition, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Förderung
- National Key Research and Development Program
- National Natural Science Foundation of China
Zitieren
APA
Yin, L., Cui, J., Lin, X., Li, N., Fan, Y., Zhang, L., Liu, J., Chong, F., Wang, C., Liang, T., Liu, X., Deng, L., Yang, M., Yu, J., Wang, X., Cong, M., Li, Z., Weng, M., Yao, Q., …, & Xu, H. (2022). Identifying cancer cachexia in patients without weight loss information: machine learning approaches to address a real-world challenge. The American Journal of Clinical Nutrition, 116(5), 1229-1239. https://doi.org/10.1093/ajcn/nqac251
Vancouver
Yin L, Cui J, Lin X, Li N, Fan Y, Zhang L, et al. Identifying cancer cachexia in patients without weight loss information: machine learning approaches to address a real-world challenge. The American Journal of Clinical Nutrition. 2022;116(5):1229-1239. doi:10.1093/ajcn/nqac251
BibTeX
@article{Yin2022,
author = {Yin, Liangyu and Cui, Jiuwei and Lin, Xin and Li, Na and Fan, Yang and Zhang, Ling and Liu, Jie and Chong, Feifei and Wang, Chang and Liang, Tingting and Liu, Xiangliang and Deng, Li and Yang, Mei and Yu, Jiami and Wang, Xiaojie and Cong, Minghua and Li, Zengning and Weng, Min and Yao, Qinghua and Jia, Pingping and Guo, Zengqing and Li, Wei and Song, Chunhua and Shi, Hanping and Xu, Hongxia},
title = {Identifying cancer cachexia in patients without weight loss information: machine learning approaches to address a real-world challenge},
journal = {The American Journal of Clinical Nutrition},
year = {2022},
volume = {116},
number = {5},
pages = {1229--1239},
doi = {10.1093/ajcn/nqac251}
}
EUVIMED